Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  European Journal of Pharmacology

• Publication date

  1993-04-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-2999(93)90958-KPMID 8482328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of Myocardial Infarct Size in Rabbits by Ramiprilat: Reversal by the Bradykinin Antagonist HOE 140

  1993cited by this paper
• Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.

  1992cited by this paper
• Cilazapril and Captopril Accelerate Recovery from Hypoxia in Myocardial Cell Aggregates in Culture

  1992cited by this paper
• Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.

  1992cited by this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• The tissue renin-angiotensin systems in cardiovascular disease.

  1992cited by this paper
• Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.

  1992cited by this paper
• Expression of the Angiotensinogen Gene and Localization of Its Protein in the Human Heart

  1992cited by this paper
• A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril

  1992cited by this paper
• Antioxidant Effects of Angiotensin-Converting Enzyme (ACE) Inhibitors: Free Radical and Oxidant Scavenging are Sulfhydryl Dependent, but Lipid Peroxidation is Inhibited by Both Sulfhydryl- and Nonsulfhydryl-Containing ACE Inhibitors

  1992cited by this paper
• Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.

  1991cited by this paper
• Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.

  1991cited by this paper
• Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.

  1991cited by this paper
• Molecular and Cell Biology of Angiotensin Receptors

  1991cited by this paper
• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

  1991cited by this paper
• Preservation of Endothelial Function by Ramipril in Rabbits on a Long‐Term Atherogenic Diet

  1991cited by this paper
• Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts.

  1991cited by this paper
• ACE inhibitors--a cornerstone of the treatment of heart failure.

  1991cited by this paper
• Cardiac angiotensinogen and its local activation in the isolated perfused beating heart.

  1990cited by this paper
• Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.

  1990cited by this paper
• [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.

  1990cited by this paper
• Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells.

  1990cited by this paper
• Angiotensin II-forming pathways in normal and failing human hearts.

  1990cited by this paper
• Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart.

  1989cited by this paper
• Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril

  1989cited by this paper
• Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.

  1989cited by this paper
• Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist

  1988cited by this paper
• Circulating versus local renin‐angiotensin system in cardiovascular homeostasis

  1988cited by this paper
• Does captopril attenuate reperfusion‐induced myocardial dysfunction by scavenging free radicals?

  1988cited by this paper
• Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion.

  1987cited by this paper
• Influence of Local Converting Enzyme Inhibition on Angiotensin and Bradykinin Effects in Ischemic Rat Hearts

  1987cited by this paper
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

  1987cited by this paper
• Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.

  1986cited by this paper
• Influence of bradykinin on glucose uptake and metabolism studied in isolated cardiac myocytes and isolated perfused rat hearts.

  1983cited by this paper
• Principles and procedures of statistics: a biometrical approach (2nd ed)

  1980cited by this paper
• Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.

  1976cited by this paper
• Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs.

  1976cited by this paper
• Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

  1971cited by this paper
• Textbook of Medical Physiology

  1961cited by this paper

• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.

  2016cites this paper
• Term Echocardiographic and Clinical Effects of Ramipril on Dogs with Asymptomatic Degenerative Mitral Valve Disease

  2013cites this paper
• Short Term Echocardiographic and Clinical Effects of Ramipril on Dogs with Asymptomatic Degenerative Mitral Valve Disease

  2013cites this paper
• Cardioprotection by ACE Inhibitors in Myocardial Ischaemia/Reperfusion

  2012cites this paper
• Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.

  2011cites this paper
• Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

  2011cites this paper
• Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.

  2010cites this paper
• Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets.

  2008cites this paper
• Pharmacologic therapeutics for cardiac reperfusion injury

  2007cites this paper
• The Role of Zofenopril in Myocardial Protection During Cardioplegia Arrest: An Isolated Rat Heart Model

  2006cites this paper
• Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.

  2006cites this paper
• Ligand triggers of classical preconditioning and postconditioning.

  2006cites this paper
• Cardioprotective Effect of Zofenopril in Perfused Rat Heart Subjected to Ischemia and Reperfusion

  2004cites this paper
• Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.

  2004cites this paper
• Role of AT1 Receptor Blockade in Reperfused Myocardial Infarction

  2003cites this paper
• Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury.

  2003cites this paper
• Should aspirin be used with angiotensin-converting enzyme inhibitors in patients with chronic heart failure?

  2003cites this paper
• Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.

  2003cites this paper
• Studies on the involvement of bradykinin using enalapril and 2-mercaptoethanol in ischemia-reperfusion induced myocardial infarction in albino rats.

  2003cites this paper
• Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin

  2002cites this paper
• Efficacy of Angiotensin II Type 1 Receptor Blockade on Reperfusion-Induced Arrhythmias and Mortality Early After Myocardial Infarction Is Increased in Transgenic Rats With Cardiac Angiotensin II Type 1 Overexpression

  2002cites this paper
• [Effect of angiotensin converting enzyme inhibitor spirapril on dimensions of experimental myocardial infarction, development of ischemic tachyarrhythmias, and ischemic adaptation of the heart].

  2002cites this paper
• Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.

  2002cites this paper
• Expressions of bradykinin B2-receptor, kallikrein and kininogen mRNAs in the heart are altered in pressure-overload cardiac hypertrophy in mice.

  2001cites this paper
• THE HEMODYNAMIC EFFECTS OF AMINOPHYLLINE, ADENOSINE, LOSARTAN AND NITRIC OXIDE ADMINISTERED SHORTLY AFTER RIGHT HEART INFARCT IN A PORCINE MODEL

  2001cites this paper
• Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.

  2001cites this paper
• Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion

  2001cites this paper
• Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKCε Proteins and cGMP

  2000cites this paper
• Possible interaction between aspirin and ACE inhibitors: update on unresolved controversy.

  2000cites this paper
• Expression of kininogen, kallikrein and kinin receptor genes by rat cardiomyocytes.

  2000cites this paper
• Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart

  2000cites this paper
• Force-length relationship in dogs as a measure of protective effect of imidapril on regional myocardial ischemia and reperfusion injury.

  2000cites this paper
• The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

  2000cites this paper
• The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats

  2000cites this paper
• Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review

  2000cites this paper
• Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.

  1999cites this paper
• The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers.

  1999cites this paper
• AT 1 -Rezeptorenblockade und experimentelle Myokardischämie/Reperfusion

  1999cites this paper
• The Angiotensin II AT1 Receptor Antagonist Candesartan at Antihypertensive Plasma Concentrations Reduces Damage Induced by Ischemia–Reperfusion

  1999cites this paper
• Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.

  1999cites this paper
• Ketamine inhibits inositol 1,4,5-trisphosphate production depending on the extracellular Ca2+ concentration in neonatal rat cardiomyocytes.

  1999cites this paper
• AT1 receptor blockade in experimental myocardial ischemia/reperfusion.

  1999cites this paper
• Structure of a kallikrein-like enzyme and its tissue localization in the dog.

  1999cites this paper
• Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias.

  1998cites this paper
• Hétérocycles à cinq chaínons contenant des substituants biphénylsulphoniques, leur procédé de préparation, leur utilisation comme médicament ou agent diagnostique ainsi médicament les contenant

  1998cites this paper
• Role of Angiotensin II in Myocardial Ischemia/ Reperfusion Injury

  1998cites this paper
• Role of Kinins in the Renoprotective Effect of Angiotensin–Converting Enzyme Inhibitors in Experimental Chronic Renal Failure

  1998cites this paper
• Exploring the Difference Between Angiotensin Converting Enzyme Inhibitors and Angiotensin II-Receptor Antagonists. A Focus on Bradykinin

  1998cites this paper
• Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs.

  1998cites this paper
• AT1 receptor blockade in experimental myocardial ischemia/reperfusion

  1998cites this paper
• Effect of Ramiprilat or Captopril on Myocardial Infarct Size: Assessment in Canine Models of Ischemia Alone and Ischemia with Reperfusion

  1998cites this paper
• EFFECTS OF LOCAL INHIBITION OF THE CARDIAC RENIN‐ANGIOTENSIN SYSTEM WITH CV‐11974 IN A CANINE ISCHAEMIA‐REPERFUSION MODEL

  1998cites this paper
• Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.

  1997cites this paper
• Purification and characterization of a kinin‐ and angiotensin II‐forming enzyme in the dog heart

  1997cites this paper
• Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction.

  1997cites this paper
• Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.

  1997cites this paper
• Angiotensin II Receptor Antagonist EXP 3174 Reduces Infarct Size Comparable with Enalaprilat and Augments Preconditioning in the Pig Heart

  1997cites this paper
• Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.

  1997cites this paper
• Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.

  1997cites this paper
• The Role of Kinins in the Cardiac Effects of ACE Inhibitors and Myocardial Ischemia

  1997cites this paper
• Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.

  1996cites this paper
• Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.

  1996cites this paper
• Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies

  1996cites this paper
• Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion.

  1996cites this paper
• Thromboxane A2 mediates the stimulation of inositol 1,4,5-trisphosphate production and intracellular calcium mobilization by bradykinin in neonatal rat ventricular cardiomyocytes.

  1996cites this paper
• Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model.

  1996cites this paper
• Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.

  1996cites this paper
• Section Review Cardiovascular & Renal: Bradykinin degradation: potential pathways for cardiovascular therapeutic use

  1996cites this paper
• Role of kinins in myocardial ischemia.

  1996cites this paper
• Angiotensin-II-Rezeptoren: Physiologische und pharmakologische Bedeutung

  1996cites this paper
• Scientific insights from clinical studies of converting-enzyme inhibitors in the failing heart.

  1995cites this paper
• The preclinical basis of the therapeutic evaluation of losartan

  1995cites this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cites this paper
• Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes.

  1995cites this paper
• Drug Differences between ACE Inhibitors in Experimental Settings and Clinical Practice

  1995cites this paper
• Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.

  1995cites this paper
• Chapter 10 Drug differences between ACE-inhibitors in experimental settings and clinical practice.

  1995cites this paper
• 2 Renin Inhibitors

  1995cites this paper
• Endothelial protection by converting enzyme inhibitors.

  1994cites this paper
• Converting enzyme inhibitors in cardiovascular therapy: current status and future potential.

  1994cites this paper
• Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.

  1994cites this paper
• The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart

  1994cites this paper
• Angiotensin-Converting Enzyme Inhibition in Infarct-Induced Heart Failure in Rats: Bradykinin Versus Angiotensin II

  1994cites this paper
• Cardioprotection by angiotensin converting enzyme inhibitors--the experimental evidence.

  1994cites this paper
• Angiotensin ii and its role in regulation of heart tolerance to ischemia/reperfusion impact. ace inhibitors and angiotensin ii at 1 -receptor antagonists

  year unknowncites this paper